Most Recent
The trial in a much anticipated shareholder class action against engineering firm WorleyParsons scheduled to commence this week has hit a roadblock, with a last minute change in the judge that will hear the matter.
Danish pharmaceutical giant Lundbeck secured $51.7 million in settlements to end infringement litigation with three generic makers over its patent for the top-selling Lexapro, the company has revealed.
A damages battle in an infringement case over two patents for the ubiquitous plastic produce containers found in grocery stores across Australia is over, with the fight settling ahead of a hearing.
Law firm Piper Alderman said Friday it would defend a sex discrimination case brought by a leading female partner against the firm's partnership, saying it did "not tolerate inappropriate workplace behaviour of any kind".
A female Piper Alderman partner has filed a sex discrimination lawsuit against the firm's other partners and has won a temporary injunction blocking the partnership from ousting her.
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi's challenge to a judge's refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.
Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant Lexapro, a judge has found.
A judge has reprimanded CIMIC Group's preparations to defend a class action against it, saying a late attempt to file critical evidence was a sign something "pretty horrible" had gone on behind the scenes.
A judge has put a proposal for a common fund order in a class action against sandalwood producer Quintis on hold as the court awaits judgment in an historic challenge to the power of courts to make common fund orders.
The law firm running a class action against sandalwood producer Quintis has pitched an unusual common fund order that subjects the firm and the funder bankrolling the case to ongoing monitoring by a cost referee.